Mitochondria: a New Intervention Target for Tumor Invasion and Metastasis

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2024 Aug 23

PMID 39179991

Authors

Quanling Zhou

Tingping Cao

Fujun Li

Ming Zhang

Xiaohui Li

Hailong Zhao

Ya Zhou

Affiliations

Soon will be listed here.

Abstract

Mitochondria, responsible for cellular energy synthesis and signal transduction, intricately regulate diverse metabolic processes, mediating fundamental biological phenomena such as cell growth, aging, and apoptosis. Tumor invasion and metastasis, key characteristics of malignancies, significantly impact patient prognosis. Tumor cells frequently exhibit metabolic abnormalities in mitochondria, including alterations in metabolic dynamics and changes in the expression of relevant metabolic genes and associated signal transduction pathways. Recent investigations unveil further insights into mitochondrial metabolic abnormalities, revealing their active involvement in tumor cell proliferation, resistance to chemotherapy, and a crucial role in tumor cell invasion and metastasis. This paper comprehensively outlines the latest research advancements in mitochondrial structure and metabolic function. Emphasis is placed on summarizing the role of mitochondrial metabolic abnormalities in tumor invasion and metastasis, including alterations in the mitochondrial genome (mutations), activation of mitochondrial-to-nuclear signaling, and dynamics within the mitochondria, all intricately linked to the processes of tumor invasion and metastasis. In conclusion, the paper discusses unresolved scientific questions in this field, aiming to provide a theoretical foundation and novel perspectives for developing innovative strategies targeting tumor invasion and metastasis based on mitochondrial biology.

References

Shao N, Qiu H, Liu J, Xiao D, Zhao J, Chen C . Targeting lipid metabolism of macrophages: A new strategy for tumor therapy. J Adv Res. 2024; 68:99-114. PMC: 11785569. DOI: 10.1016/j.jare.2024.02.009. View

Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X . Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016; 12(6):999-1014. PMC: 4922447. DOI: 10.1080/15548627.2016.1166318. View

Magrath J, Raney W, Kim Y . In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2‑positive glioblastoma cancer stem cells. Oncol Rep. 2020; 44(2):777-785. DOI: 10.3892/or.2020.7642. View

Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, Cardol P . Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J. 2004; 383(Pt. 3):491-9. PMC: 1133742. DOI: 10.1042/BJ20040256. View

Guantes R, Rastrojo A, Neves R, Lima A, Aguado B, Iborra F . Global variability in gene expression and alternative splicing is modulated by mitochondrial content. Genome Res. 2015; 25(5):633-44. PMC: 4417112. DOI: 10.1101/gr.178426.114. View

Jangamreddy J, Jain M, Hallbeck A, Roberg K, Lotfi K, Los M . Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death. Oncotarget. 2015; 6(12):10134-45. PMC: 4496345. DOI: 10.18632/oncotarget.3548. View

Zhang X, Fryknas M, Hernlund E, Fayad W, De Milito A, Olofsson M . Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments. Nat Commun. 2014; 5:3295. PMC: 3929804. DOI: 10.1038/ncomms4295. View

Liu L, Qi L, Knifley T, Piecoro D, Rychahou P, Liu J . S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2. J Biol Chem. 2019; 294(18):7516-7527. PMC: 6509482. DOI: 10.1074/jbc.RA118.004365. View

Lim S, Hroudova J, Van Bergen N, Lopez Sanchez M, Trounce I, McKenzie M . Loss of mitochondrial DNA-encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly. FASEB J. 2016; 30(6):2236-48. DOI: 10.1096/fj.201500137R. View

10.

Mi Y, Li Q, Liu B, Wang D, Liu Z, Wang T . Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis. Gastric Cancer. 2022; 26(1):69-81. PMC: 9813075. DOI: 10.1007/s10120-022-01340-7. View

11.

Singh K, Poteryakhina A, Zheltukhin A, Bhatelia K, Prajapati P, Sripada L . NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells. Biochim Biophys Acta. 2015; 1853(5):1073-86. DOI: 10.1016/j.bbamcr.2015.01.016. View

12.

Cheng L, Yang S, Yang Y, Zhang W, Xiao H, Gao H . Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker. Cancer Lett. 2012; 326(1):105-13. DOI: 10.1016/j.canlet.2012.07.031. View

13.

Li Y, Beckman K, Caberto C, Kazma R, Lum-Jones A, Haiman C . Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort. PLoS One. 2015; 10(9):e0136796. PMC: 4560485. DOI: 10.1371/journal.pone.0136796. View

14.

Power M, Kiefer M, Barr P, Reeves R . Nucleotide sequence of human mitochondrial cytochrome c oxidase II cDNA. Nucleic Acids Res. 1989; 17(16):6734. PMC: 318375. DOI: 10.1093/nar/17.16.6734. View

15.

Singh K, Roy M, Prajapati P, Lipatova A, Sripada L, Gohel D . NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1460-1476. DOI: 10.1016/j.bbadis.2019.02.018. View

16.

Hofhaus G, Attardi G . Lack of assembly of mitochondrial DNA-encoded subunits of respiratory NADH dehydrogenase and loss of enzyme activity in a human cell mutant lacking the mitochondrial ND4 gene product. EMBO J. 1993; 12(8):3043-8. PMC: 413569. DOI: 10.1002/j.1460-2075.1993.tb05973.x. View

17.

Mottaghi-Dastjerdi N, Ghorbani A, Montazeri H, Guzzi P . A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis. BMC Gastroenterol. 2023; 23(1):248. PMC: 10364406. DOI: 10.1186/s12876-023-02891-4. View

18.

Chae Y, Kim J . Cancer stem cell metabolism: target for cancer therapy. BMB Rep. 2018; 51(7):319-326. PMC: 6089865. DOI: 10.5483/bmbrep.2018.51.7.112. View

19.

Lu X, Liu Q, Zhang J, Zhou D, Yang G, Li M . Overexpression Promotes Cell Migration and Proliferation via Regulation of Autophagy and Predicts a Poor Prognosis in Lung Cancer Cases. Cancer Manag Res. 2020; 12:7703-7714. PMC: 7457709. DOI: 10.2147/CMAR.S262466. View

20.

Wu J, Deng Z, Zhu Y, Dou G, Li J, Huang L . [Overexpression of miR-431-5p impairs mitochondrial function and induces apoptosis in gastric cancer cells the Bax/Bcl-2/caspase3 pathway]. Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(4):537-543. PMC: 10202784. DOI: 10.12122/j.issn.1673-4254.2023.04.05. View